These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16799610)

  • 21. Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease (SM-AHNMD) in an infant patient.
    Kawakami T; Haga T; Soma Y; Nagae C; Kinoshita A
    J Dermatol; 2014 Aug; 41(8):761-3. PubMed ID: 25099159
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Ustun C; Corless CL; Savage N; Fiskus W; Manaloor E; Heinrich MC; Lewis G; Ramalingam P; Kepten I; Jillella A; Bhalla K
    Leuk Res; 2009 May; 33(5):735-41. PubMed ID: 18986703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic mastocytosis with an associated non mast cell lineage clonal hematological disease in a child.
    Sharma S; Harbhajanka A; Jain A; Seth A
    Indian J Pathol Microbiol; 2011; 54(4):854-6. PubMed ID: 22234140
    [No Abstract]   [Full Text] [Related]  

  • 24. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease.
    Parker RI
    J Invest Dermatol; 1991 Mar; 96(3):47S-51S. PubMed ID: 2002263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to a review series on rare systemic hematologic disorders.
    Berliner N; Sehn L
    Blood; 2020 Apr; 135(16):1305. PubMed ID: 32106304
    [No Abstract]   [Full Text] [Related]  

  • 26. Munchausen's syndrome with rare hematological disorder, systemic mastocytosis: a case report.
    Baweja R; Baweja R; Hameed A
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E35-8. PubMed ID: 24026737
    [No Abstract]   [Full Text] [Related]  

  • 27. Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
    Gruson B; Lortholary O; Canioni D; Chandesris O; Lanternier F; Bruneau J; Grosbois B; Livideanu C; Larroche C; Durieu I; Barete S; Sevestre H; Diouf M; Chaby G; Marolleau JP; Dubreuil P; Hermine O; Damaj G
    Br J Haematol; 2013 May; 161(3):434-42. PubMed ID: 23432617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart transplantation in a patient with systemic mastocytosis.
    Moro JA; Almenar L; Jarque I; Martinez-Dolz L; Hernández MD; Crespo M; Salvador A
    J Heart Lung Transplant; 2008 Jun; 27(6):689-91. PubMed ID: 18503972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A "foamy" mastocytosis case.
    Kim R; Lhermitte L
    Blood; 2018 Feb; 131(5):586. PubMed ID: 29437608
    [No Abstract]   [Full Text] [Related]  

  • 30. Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder.
    Pardanani A; Kimlinger TK; Reeder TL; Li CY; Tefferi A
    Br J Haematol; 2003 Feb; 120(4):691-4. PubMed ID: 12588358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
    Arredondo AR; Gotlib J; Shier L; Medeiros B; Wong K; Cherry A; Corless C; Arber DA; Valent P; George TI
    Am J Hematol; 2010 Aug; 85(8):600-6. PubMed ID: 20658589
    [No Abstract]   [Full Text] [Related]  

  • 32. Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
    Chantorn R; Shwayder T
    Pediatr Dermatol; 2012; 29(5):605-9. PubMed ID: 22329485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic mastocytosis. Classification, symptoms, therapy].
    Kraemer DM; Grunewald SM; Kolb-Mäurer A
    Med Klin (Munich); 2004 Mar; 99(3):131-6. PubMed ID: 15024485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review.
    Stoecker MM; Wang E
    Arch Pathol Lab Med; 2012 Jul; 136(7):832-8. PubMed ID: 22742558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic mastocytosis in association with chronic lymphocytic leukemia: a rare diagnosis.
    Ault P; Lynn A; Tam CS; Medeiros LJ; Keating MJ
    Leuk Res; 2007 Dec; 31(12):1755-8. PubMed ID: 17521719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic mast cell disease associated with the hypereosinophilic syndrome.
    McElroy EA; Phyliky RL; Li CY
    Mayo Clin Proc; 1998 Jan; 73(1):47-50. PubMed ID: 9443678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoblastic lesions in systemic mastocytosis associated with hematological malignancy.
    Gener Ricós G; Xicoy Cirici B; Tapia Melendo G
    Med Clin (Barc); 2021 May; 156(9):469-470. PubMed ID: 32461026
    [No Abstract]   [Full Text] [Related]  

  • 40. Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature.
    Simon J; Lortholary O; Caillat-Vigneron N; Raphaël M; Martin A; Brière J; Barète S; Hermine O; Casassus P;
    Pathol Biol (Paris); 2004 Jun; 52(5):294-9. PubMed ID: 15217717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.